Adrenal Gland Pheochromocytoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
NF1 mutations tended to cluster in the CSR over the RAS-GAP domain, suggesting that CSR plays a more prominent role in individuals with NF1-pheochromocytoma than in NF1 individuals without this tumor.
|
17426081 |
2007 |
Adult Hodgkin Lymphoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
HA117 expression was closely related to the clinical stage of HL (P=0.004) and to the International Prognostic Index score, mediastinal lesions, and clinical stages of NHL (P=0.01, 0.03, and 0.01).
|
23619123 |
2014 |
Aggressive periodontitis, generalized
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
A total of 84 patients with generalized aggressive periodontitis (GAP,n:29), generalized chronic periodontitis (GCP, n:25), peri-implantitis (PI,n:14), localized aggressive periodontitis (LAP,n:8) and refractory chronic periodontitis (RP,n:8) were consecutively selected from the archives of the Oral Microbiological Diagnostic Laboratory.
|
25638399 |
2015 |
alpha-Thalassemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
PCR-GAP, MLPA and FISH analyses established the cause of the α-thalassemia.
|
26753516 |
2016 |
alpha^+^ Thalassemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
PCR-GAP, MLPA and FISH analyses established the cause of the α-thalassemia.
|
26753516 |
2016 |
Alzheimer's Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
Here, we report the first recapitulation of the selective BFC neuronal loss that is typical of human AD in a mouse model termed GAP.
|
27193825 |
2016 |
Anastomosis
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
HA117 expression in stenotic segment was higher compared to proximal anastomosis and dilated segment (p < 0.05).
|
25120773 |
2014 |
Anastomosis
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
The level of HA117 RNA was significantly higher in the stenotic segment compared to proximal anastomosis (P < 0.05).
|
26097584 |
2015 |
Antibody measurement (procedure)
|
0.100 |
GeneticVariation
|
group |
GWASCAT |
Genome wide association study (GWAS) of Chagas cardiomyopathy in Trypanosoma cruzi seropositive subjects.
|
24324551 |
2013 |
Aortic Aneurysm
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Here we explore the role of ARHGAP18, a novel Rho GAP expressed by smooth muscle cells (SMCs), in the pathogenesis of TAA.
|
28701309 |
2017 |
Astrocytoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
These results support a role for neurofibromin as the critical GAP in the molecular pathogenesis of NF1 astrocytomas.
|
11005256 |
2000 |
Ataxia
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
Dysregulation of RGS6 expression in human patients could potentially contribute to loss of motor coordination and, thus, pharmacological manipulation of RGS6 levels might represent a viable means to treat patients with ataxias of cerebellar origin.
|
22179605 |
2012 |
Atrial Fibrillation
|
0.010 |
Biomarker
|
disease |
BEFREE |
Ablation of the major regulator of this pathway, Rgs6, in mice results in irregular cardiac rhythmicity and increases susceptibility to atrial fibrillation.
|
24204714 |
2013 |
Autoimmune Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
Regulation of thymocyte trafficking by Tagap, a GAP domain protein linked to human autoimmunity.
|
29895617 |
2018 |
Back Pain
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
The GAP portal will be designed to be user-friendly and present information on back pain tailored for either patients or physicians in form of brief fact sheets, educative videos, info-graphics, animations and glossaries.
|
30803433 |
2019 |
Bladder Neoplasm
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
When the SNPs were analyzed separately, the RGS6-rs2074647 (C-->T) polymorphism conferred the greatest overall reduction in risk of bladder cancer (odds ratio, 0.66; 95% confidence interval, 0.46-0.95).
|
15375002 |
2004 |
Breast Carcinoma
|
0.060 |
Biomarker
|
disease |
BEFREE |
Transduction of the breast cancer cell line 4T1 with adenoviral vectors encoding the HA117 gene and the green fluorescence protein gene (GFP) (Ad-GFP-HA117), the MDR1 and GFP (Ad-GFP-MDR1) or GFP (Ad-GFP) was respectively carried out.
|
20642825 |
2010 |
Breast Carcinoma
|
0.060 |
Biomarker
|
disease |
BEFREE |
Surprisingly, RGS6-induced apoptosis in both breast cancer cells and mouse embryonic fibroblasts does not require its GAP activity toward G proteins.
|
21041304 |
2011 |
Breast Carcinoma
|
0.060 |
Biomarker
|
disease |
BEFREE |
Connexin26 (Cx26), a component of GAP junctions and until recently believed to be a tumor suppressor gene, has been shown to play an important role in lymphatic invasion as well as lymph node and distant metastases in squamous lung cancer and breast cancer.
|
18191019 |
2008 |
Breast Carcinoma
|
0.060 |
Biomarker
|
disease |
BEFREE |
Our finding that RGS6 is downregulated in all human breast cancer subtypes independent of their molecular classification indicates that obtaining a means to restore the growth suppressive and pro-apoptotic actions of RGS6 in breast might be a viable means to treat a large spectrum of breast tumors.
|
23598467 |
2013 |
Breast Carcinoma
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
Standing in the GAP : To formulate a novel radioimmunotherapy regime to improve the long-term outcome in breast cancer.
|
29421981 |
2018 |
Breast Carcinoma
|
0.060 |
AlteredExpression
|
disease |
BEFREE |
Finally, our data in melanoma and breast carcinoma transfection systems suggest that the biochemical mechanism of nm23 suppressive activity is likely not due to its nucleoside diphosphate kinase activity, association with GAP proteins, or secretion from cells.
|
8347849 |
1993 |
Bronchiectasis
|
0.010 |
Biomarker
|
disease |
BEFREE |
LCI correlated with DL<sub>CO</sub> corrected for haemoglobin (corrDL<sub>CO</sub> ; r = -0.49, P = 0.016), bronchiectasis score (r = 0.45, P = 0.024) and the GAP stage (r = 0.59, P = 0.002), but not with FVC.FVC was not related to bronchiectasis.
|
29573509 |
2018 |
C-reactive protein measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders.
|
30388399 |
2018 |
Carcinogenesis
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
RGS6 loss dramatically accelerates BBN-induced bladder carcinogenesis, with RGS6-/- mice consistently displaying more advanced pathological lesions than RGS6+/+ mice.
|
27713144 |
2016 |